Media Releases

Student Receives International Honour

Student Receives International Honour

The Centenary Institute is pleased to announce that PhD candidate Jonathan Nambiar has received the prestigious honour of representing Australia at the Novartis International Biotechnology Leadership Camp (BioCamp). 

BioCamp is a pioneering four-day training program for entrepreneurial, postgraduate students in science or economics who are interested in pursuing a career in biotechnology.  This year, only 60 students from over 24 countries were chosen by Novartis to attend the camp held in Cambridge, Massachusetts. 

 Nambiar is the first Australian to participate in the camp in the past three years.  The young researcher was chosen by Novartis because of his impressive resume; having received business training through a Graduate Certificate in Innovation and Enterprise, from the University of Sydney Faculty of Economics and Business.

In October, Nambiar will travel to the US, where he will gain insight into the challenges and opportunities of the biotechnology industry through seminars led by biotech leaders from around the world.  

At Centenary, Nambiar is working on developing Tuberculosis vaccines.  The budding young scientist will submit his PhD thesis earlier next year and plans to undertake postdoctoral work overseas before moving into the biotechnology industry to develop medical research into new and improved diagnostics, devices, treatments and preventative technologies.

“I am privileged to represent Centenary Institute at this international camp.  Centenary has a mindset to make the results of its research available to the public by providing the groundwork that will lead to new drugs, vaccines and diagnostics for diseases that affect people throughout the world.”

Professor Mathew Vadas, Executive Director of the Centenary Institute says, “Jonathan is one of the many shining examples of talented young minds at Centenary.  The Institute is proud to support these students who will undoubtedly drive the future of medical research, and ultimately find cures for the diseases that affect us the most.”